Vimarsana
Biggest News Aggregation in the World

Synapse Labs News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Synapse Labs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Synapse Labs Today - Breaking & Trending Today

Here are the Arizona technology industry game-changers to watch - Vimarsana News

Here are the Arizona technology industry game-changers to watch

The technology industry in Arizona is energized and growing! Here are the Arizona technology industry game-changers to watch.

This is why some popular generic medicines sold in Spain may be withdrawn - Vimarsana News

This is why some popular generic medicines sold in Spain may be withdrawn

The measure, recommended by the EMA, affects drugs dispensed in countries within the European Union

Europe suspends hundreds of generic drugs over serious data concerns - Vimarsana News

Europe suspends hundreds of generic drugs over serious data concerns

Some 365 generic drugs have had their European Union marketing authorisations suspended after an investigation raised concerns about the reliability of the company that tested them.1 The European Medicines Agency’s human medicines committee reviewed 400 generic medicines that have been tested by Synapse Labs, a contract research organisation (CRO) located in Pune, India.2 Of these, just 35 …

Source: bmj.com
EMA committee recommends suspension of almost 400 medicines owing to flawed studies - Vimarsana News

EMA committee recommends suspension of almost 400 medicines owing to flawed studies

The Pharmaceutical Journal from the Royal Pharmaceutical Society

19 medicines in Sweden are under investigation in a major EMA inquiry - Vimarsana News

19 medicines in Sweden are under investigation in a major EMA inquiry

19 medicines marketed in Sweden are affected by an ongoing extensive European investigation into suspected fraud at an Indian contract research organisation. Among them are medicines for HIV, epilepsy, cancer and Parkinson’s, which may be withdrawn unless new evidence can be provided that they are up to standard.